Lv41
630 积分 2023-07-13 加入
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer
4小时前
已完结
Fifty years of monoclonals: the past, present and future of antibody therapeutics
7天前
已完结
Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance
8天前
已完结
Effective Antitumor Immunity Can Be Triggered by Targeting VISTA in Combination with a TLR3-Specific Adjuvant
17天前
已完结
The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review
1个月前
已完结
Scaffold Simplification Strategy Leads to a Novel Generation of Dual Human Immunodeficiency Virus and Enterovirus-A71 Entry Inhibitors
3个月前
已完结
Spatiotemporal Quantification of HER2-targeting Antibody–Drug Conjugate Bystander Activity and Enhancement of Solid Tumor Penetration
3个月前
已完结
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment
5个月前
已完结
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity
6个月前
已完结
T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice
7个月前
已完结
皖公网安备34019202002308
